IMARC Group, a leading market research company, has recently releases report titled "Clot Management Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028." The study provides a detailed analysis of the industry, including the global clot management devices market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
Report Highlights
How big is the clot management devices market?
Report Attributes
Details
Market Size in 2022
US$ 1.7 Billion
Market Forecast in 2028
US$ 2.4 Billion
Growth rate (2023 to 2028)
CAGR of 5.58%
Base Year of the Analysis
2022
Forecast Period
2023-2028
What is clot management devices?
A blood clot blocks the blood supply to certain parts of the body and can cause severe damage in the long run. However, it can be treated using different clot management devices, such as embolectomy balloon catheters, neurovascular embolectomy devices, catheter-directed thrombolysis (CDT), percutaneous thrombectomy devices and inferior vena cava filters (IVCF). These devices further help in preventing ischemic strokes, severe leg pain and heart attacks.
Request for a free sample copy of this report:https://www.imarcgroup.com/clot-management-devices-market/requestsample
What are the growth prospects and trends in the clot management devicesindustry?
The rising prevalence of cardiovascular diseases (CVDs), along with the growing number of smokers, is increasing the risk of blood clots among individuals. This represents one of the key factors bolstering the clot management devices market growth. Additionally, the escalating demand for minimally invasive (MI) surgeries over open surgeries, is further impelling the market growth. Other than this, some of the leading players in the industry are focusing on introducing technological advancements, which are expected to drive the market in the upcoming years. For instance, Penumbra, Inc., a US-based healthcare company, launched Reperfusion Catheters ACE68, which is a large-bore aspiration catheter designed to navigate tortuous vessels to facilitate extraction of clot quickly.
What is included in market segmentation?
The report has segmented the market into the following categories:
Breakup by Product Type:
- Neurovascular Embolectomy Devices
- Embolectomy Balloon Catheters
- Percutaneous Thrombectomy Devices
- Mechanical Thrombectomy
- Aspiration Thrombectomy
- Percutaneous Mechanical Thrombectomy (PMT)
- Catheter-Directed Thrombolysis Devices
- Inferior Vena Cava Filters
- Permanent
- Retrievable
Breakup by End-User:
- Hospitals
- Diagnostic Centers and Specialty Clinics
Breakup by Region:
- North America (U.S. & Canada)
- Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Others)
- Asia Pacific (China, India, Japan, South Korea, Indonesia, Australia, and Others)
- Latin America (Brazil, Mexico)
- Middle East & Africa
Who are the key players operating in the industry?
The report covers the major market players including:
- AngioDynamics Inc.
- Argon Medical Devices Inc.
- Boston Scientific Corporation
- DePuy Synthes Inc.
- Edwards Lifesciences Corporation
- iVascular S.L.U.
- Lemaitre Vascular Inc.
- Medtronic Inc.
- Straub Medical AG
- Stryker Corporation
- Teleflex Incorporated
- Vascular Solutions
Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=2131&flag=C
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: [email protected]
Follow us on Twitter: @imarcglobal
LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/